Biotech Bounce Targets

We have (as of today) 1245 US exchange-listed biotechs. I pulled them all and ranked them by inverse return since January 3, 2025 i.e. which stocks have been crushed the most. Here is the “winner.” Pretty sure the search is correct since this is showing a price adjusted price of $904k on January 3, 2025.

Obviously, this search is not helpful as is since it is going to pile all the dog shit on top.

So I filtered out stocks that were above $1.00 but below $5.00 which left me with 454. Top result.

Still a pile. So I filtered out stocks that aren’t at least 30 cents today.

That removed... ten.

It’s been a very rough couple of days/months/years for biotechs.

You get stuff like this, ReShare Lifesciences Inc NASDAQ:$RSLS which has just fallen into the channel, as would be expected in any market.

You get stuff like this Leap Therapeutics NASDAQ:$LPTX which obviously had a bad result at trial and fell through the band. Depending on cash position this is likely up for liquidation or M&A activity.